MLH1 and neoplasm: When dMMR not explained by MLH1‐hypermethylation is identified, NCCN recommends initial germline testing or paired tumor/germline and then the consideration, but not recommendation, for somatic MMR testing if germline testing is negative (NCCN guidelines, 2021).